Invention Grant
US08481739B2 3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases
有权
3,5-二取代-3H-咪唑并[4,5-b]吡啶和3,5-二取代-3H- [1,2,3]三唑并[4,5-b]吡啶化合物作为蛋白激酶的调节剂
![3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases](/docs/US/2013-07-09/US08481739B2/abs.jpg.600x600.jpg)
- Patent Title: 3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases
- Patent Title (中): 3,5-二取代-3H-咪唑并[4,5-b]吡啶和3,5-二取代-3H- [1,2,3]三唑并[4,5-b]吡啶化合物作为蛋白激酶的调节剂
-
Application No.: US13108642Application Date: 2011-05-16
-
Publication No.: US08481739B2Publication Date: 2013-07-09
- Inventor: Meyyappan Muthuppalaniappan , Srikant Viswanadha , Govindarajulu Babu , Swaroop Kumar V. S. Vakkalanka
- Applicant: Meyyappan Muthuppalaniappan , Srikant Viswanadha , Govindarajulu Babu , Swaroop Kumar V. S. Vakkalanka
- Applicant Address: IN Hyderabad CH La Chaux-de-Fonds
- Assignee: Incozen Therapeutics Pvt. Ltd.,Rhizen Pharmaceuticals SA
- Current Assignee: Incozen Therapeutics Pvt. Ltd.,Rhizen Pharmaceuticals SA
- Current Assignee Address: IN Hyderabad CH La Chaux-de-Fonds
- Agency: Blank Rome LLP
- Priority: IN1377/CHE/2010 20100517
- Main IPC: C07D513/02
- IPC: C07D513/02
![3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases](/abs-image/US/2013/07/09/US08481739B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides, inter alia, compounds of formula I as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
Public/Granted literature
Information query
